Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Obesity and leptin resistance: distinguishing cause from effect.

Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW.

Trends Endocrinol Metab. 2010 Nov;21(11):643-51. doi: 10.1016/j.tem.2010.08.002. Review.

2.

Hyperleptinemia is required for the development of leptin resistance.

Knight ZA, Hannan KS, Greenberg ML, Friedman JM.

PLoS One. 2010 Jun 29;5(6):e11376. doi: 10.1371/journal.pone.0011376.

3.

Energy intake in weight-reduced humans.

Rosenbaum M, Kissileff HR, Mayer LE, Hirsch J, Leibel RL.

Brain Res. 2010 Sep 2;1350:95-102. doi: 10.1016/j.brainres.2010.05.062. Review.

4.

Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.

Reidelberger RD, Haver AC, Apenteng BA, Anders KL, Steenson SM.

Obesity (Silver Spring). 2011 Jan;19(1):121-7. doi: 10.1038/oby.2010.136.

5.

Insights into amylin-leptin synergy.

Trevaskis JL, Parkes DG, Roth JD.

Trends Endocrinol Metab. 2010 Aug;21(8):473-9. doi: 10.1016/j.tem.2010.03.006. Review.

PMID:
20413324
6.

Hindbrain leptin receptor stimulation enhances the anorexic response to cholecystokinin.

Williams DL, Baskin DG, Schwartz MW.

Am J Physiol Regul Integr Comp Physiol. 2009 Nov;297(5):R1238-46. doi: 10.1152/ajpregu.00182.2009.

7.

Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.

Trevaskis JL, Lei C, Koda JE, Weyer C, Parkes DG, Roth JD.

Obesity (Silver Spring). 2010 Jan;18(1):21-6. doi: 10.1038/oby.2009.187.

8.

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.

Korner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, Salas R, Taveras C, Schrope B, Bessler M.

Int J Obes (Lond). 2009 Jul;33(7):786-95. doi: 10.1038/ijo.2009.79.

9.

Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.

Trevaskis JL, Coffey T, Cole R, Lei C, Wittmer C, Walsh B, Weyer C, Koda J, Baron AD, Parkes DG, Roth JD.

Endocrinology. 2008 Nov;149(11):5679-87. doi: 10.1210/en.2008-0770.

PMID:
18669592
10.

Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats.

Reidelberger RD, Haver AC, Chelikani PK, Buescher JL.

Am J Physiol Regul Integr Comp Physiol. 2008 Aug;295(2):R449-58. doi: 10.1152/ajpregu.00040.2008.

11.

Molecular and neural mediators of leptin action.

Robertson SA, Leinninger GM, Myers MG Jr.

Physiol Behav. 2008 Aug 6;94(5):637-42. doi: 10.1016/j.physbeh.2008.04.005. Review.

12.

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.

le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T.

Ann Surg. 2007 Nov;246(5):780-5.

PMID:
17968169
13.

Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats.

Chelikani PK, Haver AC, Reidelberger RD.

Am J Physiol Regul Integr Comp Physiol. 2007 Nov;293(5):R1798-808.

14.

Differential accessibility of circulating leptin to individual hypothalamic sites.

Faouzi M, Leshan R, Björnholm M, Hennessey T, Jones J, Münzberg H.

Endocrinology. 2007 Nov;148(11):5414-23.

PMID:
17690165
15.

Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.

Chelikani PK, Haver AC, Reidelberger RD.

Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R39-46.

16.

Anthropometrical parameters and markers of obesity in rats.

Novelli EL, Diniz YS, Galhardi CM, Ebaid GM, Rodrigues HG, Mani F, Fernandes AA, Cicogna AC, Novelli Filho JL.

Lab Anim. 2007 Jan;41(1):111-9.

PMID:
17234057
17.

Central nervous system control of food intake and body weight.

Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW.

Nature. 2006 Sep 21;443(7109):289-95. Review.

PMID:
16988703
18.
19.

PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity.

Vrang N, Madsen AN, Tang-Christensen M, Hansen G, Larsen PJ.

Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R367-75.

20.

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight.

Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E, Leibel RL.

J Clin Invest. 2005 Dec;115(12):3579-86.

Items per page

Supplemental Content

Support Center